Shree Pacetronix Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Signals

8 hours ago
share
Share Via
Shree Pacetronix Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell by MarketsMojo as of 20 Jul 2026. This shift reflects a complex interplay of deteriorating technical indicators, valuation concerns, and evolving financial trends despite the company’s strong operational performance and promoter confidence.
Shree Pacetronix Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Signals

Quality Assessment: Robust Fundamentals Amidst Market Volatility

Shree Pacetronix continues to demonstrate solid financial health, underscored by a high Return on Capital Employed (ROCE) of 24.31%, signalling efficient use of capital to generate profits. The company’s Return on Equity (ROE) stands at a commendable 17.6%, reflecting attractive shareholder returns. Operating profit growth remains strong, with a compound annual growth rate of 38.30%, supported by positive quarterly results over the last three quarters.

Net sales for Q4 FY25-26 surged by 80.1% to ₹5.37 crores compared to the previous four-quarter average, while Profit Before Tax excluding other income rose 62.4% to ₹1.36 crores. The nine-month Profit After Tax of ₹2.48 crores further confirms the company’s upward earnings trajectory. Additionally, Shree Pacetronix maintains a low Debt to EBITDA ratio of 0.51 times, indicating a strong ability to service debt and manage financial risk effectively.

Promoter confidence remains high, with a 5.9% increase in promoter stake during the previous quarter, now holding 31.7% of the company. This stake accumulation is a positive signal of management’s belief in the company’s future prospects.

Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.

  • - Strong fundamental track record
  • - Consistent growth trajectory
  • - Reliable price strength

Count on This Pick →

Valuation: Attractive Yet Cautiously Priced

Despite the downgrade, Shree Pacetronix’s valuation metrics remain compelling. The stock trades at a Price to Book Value of 2.9, which is considered very attractive relative to its peers and historical averages. The company’s Price/Earnings to Growth (PEG) ratio is an exceptionally low 0.1, signalling undervaluation given its robust earnings growth of 240% over the past year.

However, the stock price has declined recently, closing at ₹138.00 on 21 Jul 2026, down 4.66% from the previous close of ₹144.75. It remains significantly below its 52-week high of ₹283.15, indicating a substantial correction. This discount relative to historical highs and peer valuations may reflect market caution amid broader sector volatility and technical signals.

Financial Trend: Strong Earnings Growth Contrasted by Market Returns

Shree Pacetronix has delivered impressive long-term returns, with a five-year gain of 742.49% and a ten-year return of 762.5%, vastly outperforming the Sensex’s 48.87% and 178.37% respectively over the same periods. The stock’s one-year return of 64.09% also surpasses the Sensex’s negative 4.95% return, highlighting its market-beating performance.

Nonetheless, short-term returns have been mixed. The stock declined 9.63% over the past week, contrasting with a 0.12% gain in the Sensex. Year-to-date, the stock is down 27.29%, significantly underperforming the Sensex’s 8.81% loss. This volatility suggests investors are reacting to recent technical and market developments despite the company’s strong earnings momentum.

Technical Analysis: Downgrade Driven by Weakening Momentum

The primary catalyst for the downgrade to Sell is the deterioration in technical indicators. The technical trend has shifted from mildly bullish to sideways, signalling uncertainty in price direction. Key weekly indicators such as the Moving Average Convergence Divergence (MACD) remain mildly bullish, but the monthly MACD has turned bearish, indicating weakening momentum over the longer term.

The Relative Strength Index (RSI) on a weekly basis is bearish, suggesting the stock is losing upward momentum, although the monthly RSI shows no clear signal. Bollinger Bands present a mixed picture: mildly bullish weekly but bullish monthly, reflecting some volatility but potential for recovery.

Daily moving averages have turned mildly bearish, reinforcing the short-term downtrend. Meanwhile, the Know Sure Thing (KST) oscillator remains bullish on both weekly and monthly charts, and Dow Theory signals are mildly bullish, indicating some underlying strength. However, these positive signals have not been sufficient to offset the overall sideways technical trend and recent price declines.

Price action today ranged between ₹135.45 and ₹147.85, closing near the lower end, which adds to the cautious technical outlook. The stock’s current micro-cap status and relatively low Mojo Score of 43.0, with a Sell grade, reflect these technical concerns.

Considering Shree Pacetronix Ltd? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this micro-cap with top-rated alternatives now!

  • - Better options discovered
  • - Healthcare Services + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Summary and Outlook

Shree Pacetronix Ltd’s downgrade from Hold to Sell by MarketsMOJO reflects a nuanced assessment balancing strong fundamental and financial performance against weakening technical momentum and valuation caution. The company’s operational metrics, including high ROCE, low leverage, and robust earnings growth, remain impressive and suggest a healthy business model with long-term potential.

However, the recent shift in technical indicators to a sideways trend, combined with short-term price declines and a modest Mojo Score of 43.0, have prompted a more cautious stance. Investors should weigh the company’s attractive valuation and strong promoter confidence against the current market volatility and technical signals.

Given the mixed signals, a conservative approach is warranted. Monitoring upcoming quarterly results and technical developments will be crucial to reassessing the stock’s investment potential in the near term.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News